VOSEVI

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jul 18, 2017

   9 yr 1 mo ago

2. Today

3. Patent 8334270 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

4. Patent 8334270 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

5. Patent 8580765 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

6. Patent 8580765 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

7. Patent 8735372 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

8. Patent 8735372 expires

   Listed drug substance patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

9. Patent 8957046 expires

   Listed method-of-use patent (U-2040) expiration.

   Mar 21, 2028

   in 1 yr 9 mo

10. Patent 8957046 expires

    Listed method-of-use patent (U-2039) expiration.

    Mar 21, 2028

    in 1 yr 9 mo

11. Patent 9085573 expires

    Listed drug substance patent expiration.

    Mar 21, 2028

    in 1 yr 9 mo

12. Patent 9085573 expires

    Listed drug substance patent expiration.

    Mar 21, 2028

    in 1 yr 9 mo

13. Patent 8334270*PED expires

    Listed listed patent expiration.

    Sep 21, 2028

    in 2 yr 4 mo

14. Patent 8580765*PED expires

    Listed listed patent expiration.

    Sep 21, 2028

    in 2 yr 4 mo

15. Patent 8735372*PED expires

    Listed listed patent expiration.

    Sep 21, 2028

    in 2 yr 4 mo

16. Patent 9085573*PED expires

    Listed listed patent expiration.

    Sep 21, 2028

    in 2 yr 4 mo

17. Patent 7964580 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

18. Patent 7964580 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

19. Patent 8633309 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

20. Patent 8633309 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

21. Patent 8889159 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

22. Patent 8889159 expires

    Listed drug substance patent expiration.

    Mar 26, 2029

    in 2 yr 10 mo

23. Patent 7964580*PED expires

    Listed listed patent expiration.

    Sep 26, 2029

    in 3 yr 4 mo

24. Patent 8633309*PED expires

    Listed listed patent expiration.

    Sep 26, 2029

    in 3 yr 4 mo

25. Patent 8889159*PED expires

    Listed listed patent expiration.

    Sep 26, 2029

    in 3 yr 4 mo

26. Patent 9284342 expires

    Listed drug substance patent expiration.

    Sep 13, 2030

    in 4 yr 4 mo

27. Patent 9284342 expires

    Listed drug substance patent expiration.

    Sep 13, 2030

    in 4 yr 4 mo

28. Patent 8618076 expires

    Listed drug substance patent expiration.

    Dec 11, 2030

    in 4 yr 7 mo

29. Patent 8618076 expires

    Listed drug substance patent expiration.

    Dec 11, 2030

    in 4 yr 7 mo

30. Patent 9284342*PED expires

    Listed listed patent expiration.

    Mar 13, 2031

    in 4 yr 10 mo

31. Patent 8618076*PED expires

    Listed listed patent expiration.

    Jun 11, 2031

    in 5 yr 1 mo

32. Patent 8575135 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

33. Patent 8575135 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

34. Patent 8921341 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

35. Patent 8921341 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

36. Patent 8940718 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

37. Patent 8940718 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

38. Patent 9868745 expires

    Listed drug substance patent expiration.

    Nov 16, 2032

    in 6 yr 6 mo

39. Patent 8575135*PED expires

    Listed listed patent expiration.

    May 16, 2033

    in 7 yr

40. Patent 8921341*PED expires

    Listed listed patent expiration.

    May 16, 2033

    in 7 yr

41. Patent 8940718*PED expires

    Listed listed patent expiration.

    May 16, 2033

    in 7 yr

42. Patent 11116783 expires

    Listed drug product patent expiration.

    Jan 30, 2034

    in 7 yr 9 mo

43. Patent 11116783 expires

    Listed drug product patent expiration.

    Jan 30, 2034

    in 7 yr 9 mo

44. Patent 9296782 expires

    Listed drug substance patent expiration.

    Jul 17, 2034

    in 8 yr 2 mo

45. Patent 11116783*PED expires

    Listed listed patent expiration.

    Jul 30, 2034

    in 8 yr 3 mo

46. Patent 10912814 expires

    Listed drug product patent expiration.

    Jun 01, 2037

    in 11 yr 1 mo

47. Patent 11338007 expires

    Listed drug product patent expiration.

    Jun 01, 2037

    in 11 yr 1 mo

48. Patent 11338007 expires

    Listed drug product patent expiration.

    Jun 01, 2037

    in 11 yr 1 mo

49. Patent 11338007*PED expires

    Listed listed patent expiration.

    Dec 01, 2037

    in 11 yr 7 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (47)